VR Adviser, LLC Diversified Active

CIK: 0001615982 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 14, 2020

Total Value ($000): $417,632 (100.0% shares, 0.0% debt)

Holdings (16)

— CONSTELLATION PHARMACEUTICALS INC 28.9%

Value ($000) $120,707 Shares 4,016,873 Est. Cost $31.43 Unrealized —

— TRILLIUM THERAPEUTICS INC 13.2%

Value ($000) $54,931 Shares 6,790,000 Est. Cost $4.04 Unrealized —

ALT ALTIMMUNE INC 11.5%

Value ($000) $48,195 Shares 4,500,000 Est. Cost $5.49 Unrealized 0.0%

RLMD RELMADA THERAPEUTICS INC 7.2%

Value ($000) $29,913 Shares 668,440 Est. Cost $40.32 Unrealized +4.9%

— SURFACE ONCOLOGY INC 6.1%

Value ($000) $25,439 Shares 3,877,895 Est. Cost $6.56 Unrealized —

KROS KEROS THERAPEUTICS INC 6.0%

Value ($000) $25,218 Shares 672,306 Est. Cost $30.81 Unrealized 0.0%

VXRT VAXART INC 5.9%

Value ($000) $24,470 Shares 2,765,000 Est. Cost $2.87 Unrealized 0.0%

— MYOVANT SCIENCES LTD 4.2%

Value ($000) $17,424 Shares 845,000 Est. Cost $20.62 Unrealized —

— MARINUS PHARMACEUTICALS INC 3.5%

Value ($000) $14,545 Shares 5,726,540 Est. Cost $2.03 Unrealized —

— INARI MEDICAL INC 2.7%

Value ($000) $11,383 Shares 235,000 Est. Cost $48.44 Unrealized —

KURA KURA ONCOLOGY INC 2.2%

Value ($000) $9,373 Shares 575,000 Est. Cost $14.42 Unrealized 0.0%

SNDX SYNDAX PHARMACEUTICALS INC 2.2%

Value ($000) $9,273 Shares 625,710 Est. Cost $15.23 Unrealized 0.0%

— AVADEL PHARMACEUTICALS PLC 2.0%

Value ($000) $8,547 Shares 1,057,827 Est. Cost $7.94 Unrealized —

ADAPY ADAPTIMMUNE THERAPEUTICS 1.9%

Value ($000) $7,827 Shares 781,940 Est. Cost $10.01 Unrealized —

— 89BIO INC 1.4%

Value ($000) $5,802 Shares 291,140 Est. Cost $25.25 Unrealized —

— SIERRA ONCOLOGY INC 1.1%

Value ($000) $4,585 Shares 378,888 Est. Cost $9.82 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	CONSTELLATION PHARMACEUTICALS INC	4,016,873	$120,707	28.9%	$31.43	—	COM	210373106
—	TRILLIUM THERAPEUTICS INC	6,790,000	$54,931	13.2%	$4.04	—	COM NEW	89620X506
ALT	ALTIMMUNE INC	4,500,000	$48,195	11.5%	$5.49	0.0%	COM NEW	02155H200
RLMD	RELMADA THERAPEUTICS INC	668,440	$29,913	7.2%	$40.32	+4.9%	COM	75955J402
—	SURFACE ONCOLOGY INC	3,877,895	$25,439	6.1%	$6.56	—	COM	86877M209
KROS	KEROS THERAPEUTICS INC	672,306	$25,218	6.0%	$30.81	0.0%	COM	492327101
VXRT	VAXART INC	2,765,000	$24,470	5.9%	$2.87	0.0%	COM NEW	92243A200
—	MYOVANT SCIENCES LTD	845,000	$17,424	4.2%	$20.62	—	COM	G637AM102
—	MARINUS PHARMACEUTICALS INC	5,726,540	$14,545	3.5%	$2.03	—	COM	56854Q101
—	INARI MEDICAL INC	235,000	$11,383	2.7%	$48.44	—	COM	45332Y109
KURA	KURA ONCOLOGY INC	575,000	$9,373	2.2%	$14.42	0.0%	COM	50127T109
SNDX	SYNDAX PHARMACEUTICALS INC	625,710	$9,273	2.2%	$15.23	0.0%	COM	87164F105
—	AVADEL PHARMACEUTICALS PLC	1,057,827	$8,547	2.0%	$7.94	—	SPONS ADR	05337M104
ADAPY	ADAPTIMMUNE THERAPEUTICS	781,940	$7,827	1.9%	$10.01	—	SPONS ADR	00653A107
—	89BIO INC	291,140	$5,802	1.4%	$25.25	—	COM	282559103
—	SIERRA ONCOLOGY INC	378,888	$4,585	1.1%	$9.82	—	COM NEW	82640U404